Halberd Files Provisional Patent on Breakthrough Obesity Treatment
Jackson Center, Pennsylvania--(Newsfile Corp. - October 25, 2021) - Halberd Corporation (OTC Pink: HALB) announces the filing of a provisional...
Year: 2021
Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx(TM) for Acute Myocarditis
Oakville, Ontario--(Newsfile Corp. - October 25, 2021) - Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) ("Cardiol" or the "Company"), a...
Trinity Life Sciences Formalizes Full Offering of Commercialization Services for Medical Technology Companies With New Center of Excellence
Inflection Point in the MedTech Industry as Companies Pivot from Sales Force-focused to Data-driven Webinar entitled “MedTech in the Post-COVID...
PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer
NEW YORK--(BUSINESS WIRE)--$PAVM--PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (“PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, and its digital health...
Freshfields Bolsters Life Sciences Practice With Addition of Partners Kristen Riemenschneider and Vinita Kailasanath
New Washington and Silicon Valley based lawyers follow hiring of leading life sciences transactions partner Adam Golden NEW YORK--(BUSINESS WIRE)--Freshfields...
Promore Pharma Announces that Scientific Article has Been Published on Clinical Study Results with Ropocamptide for Venous Leg Ulcers
STOCKHOLM, SE / ACCESSWIRE / October 25, 2021 / Promore Pharma (STO:PROMO) (FRA:8T0)Stockholm 25 October 2021 - Promore Pharma AB,...
Proton Therapy contract finalized with Advocate Radiation Oncology Affiliate in Florida
Louvain-La-Neuve, Belgium, October 24, 2021 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader...
Brain Cancer Canada Funds Canadian Research Aiming To Treat Brain Cancer
TORONTO, Oct. 24, 2021 (GLOBE NEWSWIRE) -- Brain Cancer Canada has issued a $100,000 grant to Canadian research exploring new...
Turning Point Therapeutics Presents Early Clinical Data for Repotrectinib From Care Study in Pediatric and Young Adult Patients at SIOP 2021 Virtual Congress
Early Clinical Activity and Safety Profile Support Continued Investigation of Repotrectinib in Pediatric Tumors Harboring ALK, ROS1 or NTRK AlterationsRepotrectinib...
OncXerna Therapeutics Announces New Biomarker Data from Retrospective Analysis of Results from Phase 1b Ovarian Cancer Trial of Navicixizumab Plus Paclitaxel at the ESGO 2021 Congress
62% vs. 25% overall response rates with navicixizumab plus paclitaxel in biomarker positive vs. biomarker negative patients using the Xerna™ TME...
Update Regarding LifeLabs and BCGEU Negotiations and Essential Services
Vancouver, British Columbia, Oct. 22, 2021 (GLOBE NEWSWIRE) -- LifeLabs has notified the BCGEU through the mediator that it is...
Advanced Radiation Therapy, LLC and Apollo Healthcare Announce Strategic Partnership
TYNGSBORO, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Advanced Radiation Therapy, LLC (ART) and Apollo Healthcare have today announced a...
Athenex to Provide Corporate and Financial Update for the Third Quarter 2021, on November 4, 2021
BUFFALO, N.Y., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Athenex (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development,...
Context Therapeutics® Announces Closing of Initial Public Offering, Including Full Exercise of Underwriter’s Over-allotment Option
PHILADELPHIA, Oct. 22, 2021 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (the “Company”) (Nasdaq: CNTX), a women’s oncology company developing advanced...
Kala Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
WATERTOWN, Mass., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Kala Pharmaceuticals, Inc. (NASDAQ:KALA), today announced that the Company granted non-statutory stock...
Option Care Health Announces Pricing of Offering of $500 Million 4.375% Senior Notes and Amendment and Extension of First Lien Term Loan
BANNOCKBURN, Ill., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH) (“Option Care Health” or the “Company”) announced...
FDA approves Roche’s Susvimo, a first-of-its-kind therapeutic approach for neovascular or “wet” age-related macular degeneration (nAMD)
Susvimo, previously called Port Delivery System with ranibizumab, is the first nAMD treatment in 15 years to provide an alternative...
Align Technology to Host Investor Day on October 29, 2021
TEMPE, Ariz., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN), a leading global medical device company that...
ATL (a PSI Company) Awarded $75 Million CDC NIOSH BPA to Provide Scientific, Professional and Engineering Support Services
GAITHERSBURG, Md., Oct. 22, 2021 (GLOBE NEWSWIRE) -- Advanced Technologies and Laboratories (ATL) International, Inc., a PSI company, a government...
California Veteran Jason Ross Honored with 2021 Chevy Silverado Mobility-Equipped Vehicle
Jason Ross Receives 2021 Chevy Silverado Jason Ross of Fallbrook, California, (second from left) was recently awarded a 2021 Chevy...